Restructuring	9 Months Ended
Sep. 30, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring On August 21, 2024, the Company announced a restructuring plan to reduce the Company’s workforce by approximately 32% in response to the Company's announcement on August 20, 2024 that it will halt the registration-intended PRECISION1 trial of nab-sirolimus in patients with solid tumors harboring TSC1 or TSC2 inactivating alterations. The Company recorded a total restructuring charge of $2.6 million, which consists of one-time termination benefits such as severance costs and related benefits. For the three and nine months ended September 30, 2024, the Company made cash payments related to the restructuring of $0.4 million. As of September 30, 2024, the $2.2 million one-time termination benefits remain payable and are recorded within the accrued expenses and other liabilities line item on the Company's condensed balance sheet. Restructuring payments commenced in September 2024 and will extend through December 2024.

Restructuring

9 Months Ended

Sep. 30, 2024

Restructuring and Related Activities [Abstract]

On August 21, 2024, the Company announced a restructuring plan to reduce the Company’s workforce by approximately 32% in response to the Company's announcement on August 20, 2024 that it will halt the registration-intended PRECISION1 trial of nab-sirolimus in patients with solid tumors harboring TSC1 or TSC2 inactivating alterations. The Company recorded a total restructuring charge of $2.6 million, which consists of one-time termination benefits such as severance costs and related benefits. For the three and nine months ended September 30, 2024, the Company made cash payments related to the restructuring of $0.4 million. As of September 30, 2024, the $2.2 million one-time termination benefits remain payable and are recorded within the accrued expenses and other liabilities line item on the Company's condensed balance sheet. Restructuring payments commenced in September 2024 and will extend through December 2024.